https://www.ajmc.com/view/surveillance-program-ineffective-at-detecting-cholangiocarcinoma-early-enough-for-benefit-in-patients-with-psc
0
0
11/30/22 at 6:13am
Organization
Ajmc.com
Only 2% of patients with primary sclerosing cholangitis (PSC) received a cholangiocarcinoma diagnosis, and the diagnosis was not early enough for there to be a survival benefit.
Create an account
or login to join the discussion